We are live on ! Find out more
SLRN

ACELYRIN

Delisted

SLRN was delisted on the 21st of May, 2025.

105 hedge funds and large institutions have $183M invested in ACELYRIN in 2025 Q1 according to their latest regulatory filings, with 22 funds opening new positions, 22 increasing their positions, 41 reducing their positions, and 42 closing their positions.

New
Increased
Maintained
Reduced
Closed

129% more call options, than puts

Call options by funds: $71K | Put options by funds: $31K

100% more funds holding in top 10

Funds holding in top 10: 24 (+2)

14.28% less ownership

Funds ownership: 87.69%73.41% (-14%)

16% less funds holding

Funds holding: 125105 (-20)

34% less capital invested

Capital invested by funds: $276M → $183M (-$93.8M)

46% less repeat investments, than reductions

Existing positions increased: 22 | Existing positions reduced: 41

48% less first-time investments, than exits

New positions opened: 22 | Existing positions closed: 42

Holders
105
Holders Change
-20
Holders Change %
-16%
% of All Funds
1.41%
Holding in Top 10
4
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+100%
% of All Funds
0.05%
New
22
Increased
22
Reduced
41
Closed
42
Calls
$71K
Puts
$31K
Net Calls
+$40K
Net Calls Change
+$22K
Name Holding Trade Value Shares
Change
Change in
Stake
Citigroup
51
Citigroup
New York
$132K -$10.2K -4,282 -7%
Marshall Wace
52
Marshall Wace
United Kingdom
$131K -$1.23M -518,948 -91%
Wells Fargo
53
Wells Fargo
California
$130K +$1.41K +594 +1%
LP
54
LMR Partners
United Kingdom
$124K +$119K +50,000 New
IIM
55
INTECH Investment Management
Florida
$123K +$55.3K +23,243 +87%
YCM
56
Yakira Capital Management
Connecticut
$120K +$115K +48,557 New
VIA
57
Virtus Investment Advisers
Connecticut
$115K +$25.4K +10,672 +30%
Dimensional Fund Advisors
58
Dimensional Fund Advisors
Texas
$111K -$175K -73,486 -62%
SO
59
STRS Ohio
Ohio
$109K
Mirae Asset Global ETFs Holdings
60
Mirae Asset Global ETFs Holdings
Hong Kong
$108K +$4.45K +1,872 +4%
Bank of America
61
Bank of America
North Carolina
$89.9K -$384K -161,425 -82%
CF
62
Corebridge Financial
Texas
$89.6K -$45 -19 -0.1%
PCM
63
Prelude Capital Management
New York
$89.5K -$124K -51,961 -59%
T. Rowe Price Associates
64
T. Rowe Price Associates
Maryland
$86K +$18.5K +7,777 +29%
Mariner
65
Mariner
Kansas
$77.5K +$74.6K +31,389 New
Manulife (Manufacturers Life Insurance)
66
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$70.9K +$1.46K +613 +2%
SG Americas Securities
67
SG Americas Securities
New York
$67K -$8.03K -3,378 -11%
WWM
68
Western Wealth Management
Colorado
$61.8K +$59.4K +25,000 New
CL
69
CSS LLC
Illinois
$60.7K +$58.4K +24,564 New
VOYA Investment Management
70
VOYA Investment Management
Georgia
$51.3K -$3.6K -1,514 -7%
ProShare Advisors
71
ProShare Advisors
Maryland
$50.8K -$11.3K -4,737 -19%
CUAMC
72
China Universal Asset Management Company
China
$49.9K -$2.55K -1,074 -5%
MIM
73
MetLife Investment Management
New Jersey
$45.7K -$57.9K -24,359 -57%
Nisa Investment Advisors
74
Nisa Investment Advisors
Missouri
$41K +$39.2K +16,503 +19,883%
CWM
75
CIBC World Markets
New York
$40.6K +$39.1K +16,427 New

SLRN Hedge Fund Activity: Q1 2025 in Review

105 of the 7,458 institutional investors tracked by Wall St. Rank reported a position in ACELYRIN (SLRN) for Q1 2025, worth a combined $183M — down 34% from $276M a quarter earlier.

Sellers outnumbered buyers: 42 funds closed out of SLRN and 22 opened new positions — a net loss of 20 holders — while 41 trimmed existing stakes and 22 added.

The largest buyer was Tang Capital Management, opening a new position worth an estimated $23.3M. The largest seller was T. Rowe Price Investment Management, cutting an estimated $19.6M.

  • 105 institutional investors held ACELYRIN (SLRN) as of Q1 2025, down from 125 in Q4 2024.
  • Funds reported $183M of ACELYRIN stock for Q1 2025, down 34% quarter-over-quarter.
  • 22 funds opened new ACELYRIN positions in Q1 2025 and 42 closed out, a net change of -20 holders.
  • The largest ACELYRIN buyer in Q1 2025 was Tang Capital Management, an estimated $23.3M added.
  • The largest ACELYRIN seller in Q1 2025 was T. Rowe Price Investment Management, an estimated $19.6M sold.

Based on aggregated 13F filings for Q1 2025.